127 related articles for article (PubMed ID: 8709647)
1. Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies.
Hummel JL; Lichty BD; Reis M; Dubé I; Kamel-Reid S
Leukemia; 1996 Aug; 10(8):1370-6. PubMed ID: 8709647
[TBL] [Abstract][Full Text] [Related]
2. Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
O'Brien S; Jeha S; Kantarjian H; Pisa P; Jin G; Keating M; Beran M
Leukemia; 1996 Feb; 10(2):338-44. PubMed ID: 8637244
[TBL] [Abstract][Full Text] [Related]
3. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J
Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849
[TBL] [Abstract][Full Text] [Related]
5. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
[TBL] [Abstract][Full Text] [Related]
7. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
8. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma.
Hermouet S; Sutton CA; Rose TM; Greenblatt RJ; Corre I; Garand R; Neves AM; Bataille R; Casey JW
Leukemia; 2003 Jan; 17(1):185-95. PubMed ID: 12529677
[TBL] [Abstract][Full Text] [Related]
10. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
Mohammad RM; Mohamed AN; Hamdan MY; Vo T; Chen B; Katato K; Abubakr YA; Dugan MC; al-Katib A
Leukemia; 1996 Jan; 10(1):130-7. PubMed ID: 8558918
[TBL] [Abstract][Full Text] [Related]
12. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M
Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433
[TBL] [Abstract][Full Text] [Related]
13. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
14. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
15. Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency.
Kobayashi R; Picchio G; Kirven M; Meisenholder G; Baird S; Carson DA; Mosier DE; Kipps TJ
Leuk Res; 1992 Oct; 16(10):1013-23. PubMed ID: 1383641
[TBL] [Abstract][Full Text] [Related]
16. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice.
Wong KK; Brenneman F; Chesney A; Spaner DE; Gorczynski RM
Cancer Res; 2012 Oct; 72(19):4931-43. PubMed ID: 22875025
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
de Kroon JF; Kluin-Nelemans HC; Kluin PM; Schuuring E; van Bergen CA; Oving I; Wessels H; Willemze R; Falkenburg JH
Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
[TBL] [Abstract][Full Text] [Related]
19. Tumor formation by a human pre-B leukemia cell line in scid mice is enhanced by matrigel and is associated with induction of CD10 expression.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1995 Jan; 9(1):175-84. PubMed ID: 7845014
[TBL] [Abstract][Full Text] [Related]
20. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
